<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

OUR RESOURCES

All of Biotech and Money's content, in one place.

EXECUTIVE AND EXPERT INSIGHTS

Investorview: Ingredients for growth in life sciences investment

Industrifonden is an evergreen venture capital fund with headquarters in St...

Read More

Accessing US Government Funds for Research and Development

The US Government has long been a significant source of funds for life scie...

Read More

Does Brexit affect your European patent strategy?

The process of obtaining patent protection in Europe is unaffected by Brexi...

Read More

PharmaKrysto kickstarts cystinuria drug development programme with licensing deal

Key learnings: PharmaKrysto has signed a licensing deal with Rutgers Univer...

Read More

Appleyard Lees: Applying in-house expertise to develop commercially-relevant IP strategies

Key learnings: UK-based Appleyard Lees provides clients worldwide with a fu...

Read More

Inceptua: Partnering with life sciences companies throughout a product’s lifecycle

Key learnings: Inceptua Group’s expanded breadth of capabilities across cli...

Read More

Medius Deal Watch June 2018

June has proved to be a very busy month on the deal front with significant ...

Read More

Avacta looks to deals to leverage Affimer platform’s potential

Key learnings: UK-based Avacta Group has developed Affimer® technology, an ...

Read More
View More

EXECUTIVE PUBLICATIONS AND REPORTS

Have your say in the LSX C-Suite Challenges in Life Sciences Survey 2018

What are the biggest obstacles to securing financing? What challenges do yo...

Read More

How to manage whistleblowing in life sciences

Whistleblowing, along with the impact that it can have on organisations, ha...

Read More

Infographic: Preparing for GDPR

Two years after gaining approval from the European Parliament, the General ...

Read More

INFOGRAPHIC: 2018 INVESTOR PERCEPTION SURVEY HIGHLIGHTS

This infographic presents key findings from the 2nd Biotech and Money Inves...

Read More

Read the Biotech and Money Investor Perception Survey 2018

The Investor Perception Survey 2018 is now available to download. The repor...

Read More

Infographic: 2017 Investor Perception Survey Highlights

In February 2017, Biotech and Money published its 1st Investor perception s...

Read More

A guide to successful investment in advanced therapies

The advanced therapy sector is a rapidly growing industry which offers subs...

Read More

Global therapeutic IPO market: Q3 2017 analysis

The global therapeutic IPO market has failed to maintain the upward momentu...

Read More
View More

INVESTORVIEWS

Investorview: Ingredients for growth in life sciences investment

Industrifonden is an evergreen venture capital fund with headquarters in St...

Read More

Investorview: Why people are key in life science investments

Since it was founded in 1996, European venture capital firm HealthCap has i...

Read More

Investorview: Plugging knowledge gaps to accelerate life science start-up development

Venture capital firm Hadean Ventures closed its first fund at the end of 20...

Read More

Investorview: Driving early-stage investment in UK life sciences

In March 2018, NCL Technology Ventures launched a £50 million fund to help ...

Read More

Investorview: Committing to social responsibility in healthcare investment

Swiss venture capital firm MTIP launched its first fund in 2016, achieving ...

Read More

Investor perspective: Sander Slootweg

Looking back at the past year, 2017 has proven to be a pretty successful ye...

Read More

Investorview: Proactively Bridging The Early Stage Funding Gap

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent investments

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More
VIEW MORE